tiprankstipranks
Trending News
More News >
Diagonal Bio AB (DE:9F1)
:9F1
Germany Market

Diagonal Bio AB (9F1) Financial Statements

Compare
0 Followers

Diagonal Bio AB Financial Overview

Diagonal Bio AB's market cap is currently €1.22M. The company's EPS TTM is €-0.000275223; its P/E ratio is ―; Diagonal Bio AB is scheduled to report earnings on May 14, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 23.00Kkr 203.00Kkr 407.00Kkr 20.31K
Gross Profitkr 3.13Mkr 2.05Mkr -85.00Kkr -607.55K
Operating Incomekr -11.57Mkr -15.16Mkr -11.66Mkr -607.55K
EBITDAkr -11.47Mkr 0.00kr -11.66Mkr 193.97K
Net Incomekr -11.68Mkr -16.16Mkr -11.66Mkr -583.36K
Balance Sheet
Cash & Short-Term Investmentskr 2.97Mkr 13.59Mkr 20.77Mkr 3.67M
Total Assetskr 28.51Mkr 34.03Mkr 36.01Mkr 9.97M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -2.97Mkr -13.59Mkr -20.77Mkr -3.67M
Total Liabilitieskr 7.26Mkr 2.78Mkr 2.14Mkr 1.08M
Stockholders' Equitykr 21.25Mkr 31.25Mkr 33.87Mkr 8.89M
Cash Flow
Free Cash Flowkr -9.48Mkr -20.73Mkr -19.54Mkr 226.67K
Operating Cash Flowkr -5.23Mkr -15.77Mkr -10.94Mkr 226.67K
Investing Cash Flowkr -4.25Mkr -4.96Mkr -8.59Mkr -7.97M
Financing Cash Flowkr -1.14Mkr 13.55Mkr 36.63Mkr 12.63M
Currency in SEK

Diagonal Bio AB Earnings and Revenue History

Diagonal Bio AB Debt to Assets

Diagonal Bio AB Cash Flow

Diagonal Bio AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis